These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7048877)

  • 41. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 42. [Study of the antihypertensive effect of the preparation VKB-105 (Viskaldix) in arterial hypertension].
    Ivancić R; Goldner V; Jursić M; Uchytil R; Strbo B
    Lijec Vjesn; 1984; 106(11-12):520-2. PubMed ID: 6394941
    [No Abstract]   [Full Text] [Related]  

  • 43. Verapamil in the treatment of hypertension.
    Anavekar SN; Christophidis N; Louis WJ; Doyle AE
    J Cardiovasc Pharmacol; 1981; 3(2):287-92. PubMed ID: 6166800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of pindolol and methyldopa on blood pressure and plasma norepinephrine.
    Winer N; Carter CH; Eddy H
    Am Heart J; 1982 Aug; 104(2 Pt 2):425-31. PubMed ID: 7048879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Arterial blood pressure and various biochemical parameters in the blood of patients with idiopathic hypertension treated with Viskaldix].
    Wiecek A; Kargul W; Gasior Z; Grzeszczak W
    Wiad Lek; 1985 Jul; 38(13):912-9. PubMed ID: 4060720
    [No Abstract]   [Full Text] [Related]  

  • 46. [Essential arterial hypertension. Antihypertensive effect of the beta adrenergic blockader pindolol].
    Torres Zamora M
    Prensa Med Mex; 1977; 42(3-4):127-32. PubMed ID: 917991
    [No Abstract]   [Full Text] [Related]  

  • 47. [Use of Visken-15 for treating hypertension].
    Erina EV; Megrelishvili RI; Pushkar' IuT; Beliakova EV; Lediashova GA
    Kardiologiia; 1979 Mar; 19(3):46-52. PubMed ID: 372668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypertension in the elderly. Its diagnosis in general practice and treatment with felodipine and metoprolol.
    Davis RH; Burton RH; Freeling P; Graham-Evans JN; Goves JR; Orne-Smith EA; Osborne CJ; Ward DE
    Drugs; 1987; 34 Suppl 3():149-50. PubMed ID: 3327675
    [No Abstract]   [Full Text] [Related]  

  • 49. [Viskaldix in the treatment of arterial hypertension].
    Josipović V; Stefanović M; Kozarević D; Kozarević D; Knezević S
    Lijec Vjesn; 1984; 106(11-12):523-5. PubMed ID: 6394942
    [No Abstract]   [Full Text] [Related]  

  • 50. Trials of the treatment of mild hypertension. An interim analysis.
    Lancet; 1982 Jan; 1(8264):149-56. PubMed ID: 6119523
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased.
    Wilson M; Morgan G; Morgan T
    Br J Clin Pharmacol; 1976 Oct; 3(5):857-61. PubMed ID: 788758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of hemodynamic changes in patients with primary arterial hypertension after treatment with a combination of pindolol and clopamide (Viskaldix)].
    Wyrzykowski B; Suchecka-Rachoń K
    Kardiol Pol; 1991; 34(5):286-91. PubMed ID: 1921111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of 'responders' to long-term pindolol therapy from phasic changes in cardiovascular function during acute intravenous administration in essential hypertension.
    Logan AG; Milne BJ; Colman JM
    Clin Invest Med; 1978; 1(3-4):147-52. PubMed ID: 42504
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol.
    Rosenfeld J; Bott-Kanner G; Boner G; Nissenkorn A; Friedman S; Ovadia J; Merlob P; Reisner S; Paran E; Zmora E
    Eur J Obstet Gynecol Reprod Biol; 1986 Aug; 22(4):197-204. PubMed ID: 3743860
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Sievert A; Aurell M; Hansson L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S102-4. PubMed ID: 2455104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Use of viskaldix in the treatment of patients with hypertension].
    Mikunis RI; Klipatskiĭ AA; Monastyrskiĭ IuI; Kirichenko VI; Pshelutskiĭ FF
    Klin Med (Mosk); 1988 Oct; 66(10):62-4. PubMed ID: 3070156
    [No Abstract]   [Full Text] [Related]  

  • 57. Pindolol once daily in the treatment of hypertension.
    Frithz G
    Ups J Med Sci; 1976; 81(3):151-4. PubMed ID: 797084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Experience with Viskaldix].
    Jezersek P
    Lijec Vjesn; 1984; 106(11-12):518-20. PubMed ID: 6394940
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA
    Arq Bras Cardiol; 1981 Sep; 37(3):219-24. PubMed ID: 7052028
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical pharmacology of adrenergic-blocking drugs.
    Louis WJ; Rand MJ; McNeil JJ; Drummer O; Jarrott B
    Cardiology; 1979; 64 Suppl 1():96-104. PubMed ID: 42490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.